INCYTE CORPORATION Payments to Acquire Long-term Investments
INCYTE CORPORATION (INCY) reported Payments to Acquire Long-term Investments of $7.88 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireLongtermInvestments · last filed 2026-02-10
- INCYTE CORPORATION payments to acquire long-term investments for the quarter ending 2024-12-31 was $0.00.
- INCYTE CORPORATION payments to acquire long-term investments for the quarter ending 2023-12-31 was $0.00.
- INCYTE CORPORATION payments to acquire long-term investments for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- INCYTE CORPORATION payments to acquire long-term investments for the quarter ending 2021-12-31 was $24.85M.
- INCYTE CORPORATION payments to acquire long-term investments for fiscal 2025 was $7.88M.
- INCYTE CORPORATION payments to acquire long-term investments for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- INCYTE CORPORATION payments to acquire long-term investments for fiscal 2023 was $10.00M.
- INCYTE CORPORATION payments to acquire long-term investments for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Long-term Investments 3 month | Payments to Acquire Long-term Investments 6 month | Payments to Acquire Long-term Investments 9 month | Payments to Acquire Long-term Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $7.88M 10-K · filed 2026-02-10 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $0.00 10-K · filed 2026-02-10 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-10-29 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $10.00M 10-K · filed 2026-02-10 | ||
| 2023-09-30 | $10.00M 10-Q · filed 2024-10-29 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $0.00 10-K · filed 2025-02-10 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-10-31 | |||
| 2021-12-31 | $24.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $24.85M derived: sum of 2 quarters · filed 2024-02-13 | $24.85M derived: sum of 3 quarters · filed 2024-02-13 | $33.51M 10-K · filed 2024-02-13 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $0.00 derived: sum of 2 quarters · filed 2022-11-01 | $8.66M 10-Q · filed 2022-11-01 | $8.66M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $8.66M 10-Q · filed 2022-08-02 | $8.66M derived: sum of 3 quarters · filed 2023-02-07 | $8.66M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $8.66M 10-Q · filed 2022-05-03 | $8.66M derived: sum of 2 quarters · filed 2023-02-07 | $8.66M derived: sum of 3 quarters · filed 2023-02-07 | $8.66M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $0.00 derived: sum of 2 quarters · filed 2023-02-07 | $0.00 derived: sum of 3 quarters · filed 2023-02-07 | $95.47M 10-K · filed 2023-02-07 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $95.47M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $95.47M 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | $95.47M 10-Q · filed 2021-05-04 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $0.00 derived: sum of 2 quarters · filed 2021-02-09 | $8.94M 10-K · filed 2021-02-09 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $8.94M 10-Q · filed 2019-10-29 | ||
| 2018-06-30 | $8.94M 10-Q · filed 2019-07-30 | |||
| 2017-12-31 | $123.89M 10-K · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |